European Investment Bank

Orano is a leading global company based in Courbevoie, France, specializing in nuclear power and renewable energy solutions. The company offers a comprehensive range of services covering every stage of the nuclear fuel cycle, including reactor design, construction, and operational support. With a strong emphasis on safety and advanced technology, Orano is committed to supplying low-carbon power generation solutions. Additionally, it engages in renewable energy initiatives through partnerships aimed at developing high-tech solutions. As energy demand increases and the need for sustainable practices intensifies, Orano focuses on creating cleaner energy alternatives that contribute to reducing greenhouse gas emissions. The company aims to enhance transparency, coherence, and efficiency in its operations while preparing for the future energy landscape.

Universal Diagnostics, S.L. is a biomedicine company based in Seville, Spain, with an additional office in San Francisco, California. Founded in 2012, the company focuses on developing blood-based tests for the early detection of various cancers, including colorectal, lung, liver, pancreatic, and gastric cancers. Its diagnostic platform utilizes proprietary methylation marker panels, allowing for minimally invasive testing that can be performed using standard laboratory equipment. The first test developed by Universal Diagnostics is aimed at colorectal cancer screening, identifying individuals who may require further examination through colonoscopy. The company emphasizes the importance of early detection, as this can significantly improve treatment options and survival rates. To advance its research and development efforts, Universal Diagnostics collaborates with international research institutions, hospitals, universities, and biobanks worldwide.

Nomagic, Inc. is a company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce warehouses. By providing smart pick-and-place robotic systems, Nomagic enhances efficiency, flexibility, and reliability in the logistics process. Their technology automates repetitive tasks, reduces fulfillment costs, and addresses labor shortages, allowing warehouses to operate seamlessly around the clock. The company's robots have already been implemented on packing lines at Cdiscount, a leading French e-commerce platform. Utilizing artificial intelligence, Nomagic's systems continuously learn and adapt to changing conditions, improving the agility of warehouse operations and ensuring reliable delivery of goods.

Royal Schiphol Group N.V. is the owner and operator of Amsterdam Airport Schiphol, the national airport of the Netherlands, as well as other airports including Rotterdam The Hague Airport and Lelystad Airport. The company manages and develops airport operations, providing essential services and facilities to airlines, travelers, handling agents, and logistics providers. It also grants concessions for various shops, restaurants, and entertainment options within the airport, while operating its own retail spaces and car parks. Additionally, Royal Schiphol Group develops and manages properties related to airport activities, offering various locations and rental agreements for businesses and logistics service providers. Established in 1958 and headquartered in Schiphol, the company plays a crucial role in aviation and transportation in the Netherlands and beyond.

Samotics is a Dutch technology company that specializes in an AI-powered condition monitoring platform aimed at enhancing the availability of industrial electric motors and rotating equipment. By utilizing data from sensors and operational systems, Samotics' solution offers predictive insights that help companies identify and address potential equipment failures before they occur. This proactive approach enables organizations to reduce unplanned downtime, lower operational costs, and minimize energy waste. The company serves a diverse range of global industrial clients, including notable names such as Anglian Water, ArcelorMittal, and Nobian, helping them optimize their operations and improve the efficiency of their critical equipment.

Median Technologies SA specializes in the development and marketing of software products and platforms for medical image analysis, primarily focusing on oncology. Founded in 2002 and headquartered in Valbonne, France, the company operates internationally, offering solutions that enhance the diagnosis and treatment of cancer patients. Its key products include iBiopsy, an imaging platform that utilizes AI for biomarker identification, and iSee, which supports image analysis and management in clinical trials. Additionally, Median provides a range of imaging contract research services, including study startup, data management, and scientific consulting to optimize clinical trials. The company collaborates with a contract research organization and Canon to enhance its imaging technologies and services, aiming to improve patient care and streamline drug development processes.

NXP Semiconductors N.V. is a prominent supplier of high-performance mixed-signal semiconductor products, headquartered in Eindhoven, the Netherlands. Founded in 2006, the company offers a diverse product portfolio that includes microcontrollers, application processors, communication processors, and various wireless connectivity solutions such as Bluetooth, Wi-Fi, and Near Field Communications. NXP's technology is integral to multiple applications across automotive, industrial, Internet of Things, mobile, and communication infrastructure sectors. The company has established a significant presence in the automotive market, providing essential components for powertrains, infotainment systems, and safety systems. Additionally, NXP maintains operations in over 25 countries and has formed strategic partnerships, including collaboration with Amazon Web Services to enhance connected vehicle solutions.

EDP Renewables is a global renewable energy company focused on creating value, innovation, and sustainability. Operating in markets worldwide, they are expanding their presence to new regions to lead in each market and provide value to stakeholders and shareholders. With a history of developing wind farms since 1996, EDPR manages assets in the European Union through EDPR Europe and in the United States and Canada through EDPR North America. As a majority shareholder, Energias de Portugal, S.A. (EDP) contributes to EDPR's operational excellence. EDP Group, Portugal's largest industrial group, is a key player in the Iberian Peninsula's energy sector, with interests in electricity and gas generation, distribution, and supply in Portugal, Spain, and Brazil. By focusing on high-quality assets and attractive markets with growth prospects and stable regulatory structures, EDPR aims to generate profits and maintain its position as a leader in the renewable energy industry.

Energias de Portugal (EDP) is a prominent global energy company based in Lisbon, Portugal, founded in 1976. It operates primarily in the electricity and gas sectors, offering services in generation, distribution, and trading. EDP is one of the largest energy operators in the Iberian Peninsula and ranks as the third-largest producer of wind energy in the region. The company emphasizes value creation, innovation, and sustainability, reflecting its commitment to customers, society, and the environment. EDP's diverse workforce spans multiple continents, fostering a culture that respects the various markets in which it operates. Additionally, EDP is recognized for its performance in transparency and sustainability, as evidenced by its inclusion in the Dow Jones Sustainability Indexes.

Emerging Markets Global Advisory is an investment bank based in London, United Kingdom, specializing in advisory services for financial institutions, institutional investors, and large-cap and middle-market companies across various industries. The firm provides a comprehensive range of investment banking services, including mergers and acquisitions advisory, corporate finance, and capital raising, encompassing both debt and equity. Additionally, it offers expertise in leveraged buyouts, restructurings, valuation analysis, recapitalizations, and divestitures. Emerging Markets Global Advisory serves clients in diverse sectors such as financial services, manufacturing, transportation, agriculture, food, energy, and communications, making it a versatile partner for organizations seeking strategic financial guidance.

Cellectis S.A. is a clinical-stage biotechnological company based in Paris, France, focused on developing innovative immuno-oncology therapies using gene-edited T-cells. The company specializes in allogeneic Chimeric Antigen Receptor T-cell (CAR-T) products, with a portfolio that includes several product candidates targeting various hematologic malignancies. Notable candidates include UCART19, aimed at treating CD19-expressing hematologic cancers such as acute lymphoblastic leukemia; UCART123 for acute myeloid leukemia; and UCARTCS1 and ALLO-715 for multiple myeloma. In addition to its therapeutic efforts, Cellectis also produces high oleic soybean oil and other soybean products, as well as fiber wheat. The company collaborates with various strategic partners, including Allogene Therapeutics and The University of Texas M.D. Anderson Cancer Center. Founded in 1999, Cellectis continues to advance its mission of eradicating cancer through cutting-edge gene-editing technologies.

Marinomed Biotech AG is a biopharmaceutical company based in Vienna, Austria, specializing in the development of innovative therapies for respiratory and ophthalmological diseases. Founded in 2006, the company operates primarily through two technology platforms: Marinosolv and Carragelose. Marinosolv enables the creation of stable aqueous formulations for poorly soluble compounds, enhancing their bioavailability and therapeutic efficacy, while Carragelose offers antiviral solutions aimed at respiratory viruses. Marinomed's product portfolio includes nasal sprays, throat sprays, and lozenges designed to block viruses and alleviate symptoms associated with conditions such as cough, cold, influenza, and allergic rhinitis. The company collaborates with partners to market its products globally, focusing on improving treatment options for patients with sensitive tissues in the nose and eyes.

Enpal GmbH is a Berlin-based company founded in 2017 that specializes in providing comprehensive renewable energy solutions, primarily through the installation and operation of solar panels for residential electricity generation. The company offers a range of products, including solar panels, batteries, wallboxes, heat pumps, and energy management systems, catering to customers in Germany and Italy. Enpal initially adopted a sales-based model but successfully transitioned to a lease model that requires no upfront payment and includes installation, insurance, and maintenance services. This approach has resulted in significant growth, with over 60,000 solar PV systems installed and revenues exceeding 400 million euros as of 2022. Enpal employs more than 1,000 team members, including over 200 local installer teams, and has opened several satellite offices to enhance customer service across its markets. The company has received numerous awards for its contributions to sustainability and customer service, positioning itself as a leader in the solar PV installation sector in Germany.

Polski Koncern Naftowy Orlen is a prominent energy conglomerate operating primarily in the oil and gas sector. The company refines and distributes oil in Poland, the Czech Republic, Germany, and Lithuania, processing crude oil into various products such as gasoline, diesel, fuel oil, and aviation fuel through its network of refineries. In addition to refining, Orlen produces petrochemicals and chemical feedstock. The company is also involved in exploration and production activities in Poland and Canada. Orlen's extensive logistics infrastructure supports its operations, featuring both surface and underground storage depots, as well as a long-distance pipeline network, which facilitates the distribution of oil products through a widespread network of service stations.

GEWOBA Aktiengesellschaft Wohnen und Bauen is a prominent real estate company based in Bremen, Germany, founded in 1924. The company specializes in residential real estate management, acquisition, construction, urban development, leasing, and brokerage services. In addition to its real estate operations, GEWOBA also oversees the Gewoba Foundation, established in 1999, which focuses on providing commercial and residential rental properties, along with property management and development services. The foundation's assets are managed by a dedicated board of directors, ensuring effective governance and operational oversight.

Vay is a Berlin-based deep technology company that is on track to launch the first driverless, safety-certified, commercial fleet on European public streets. The company aims to revolutionize urban transportation by enabling remote-controlled cars, offering a safer, more efficient solution for ride-hailing and vehicle-sharing services. Vay’s unique approach blends the advantages of self-driving technology with human supervision to ensure safety and adaptability in complex driving environments. Their goal is to reduce urban congestion, cut emissions, and make mobility more sustainable while providing a seamless transportation experience for users.

NVision Imaging Technologies GmbH, founded in 2015 and based in Ulm, Germany, specializes in the development and commercialization of innovative imaging and sensing applications grounded in quantum physics. The company has created a platform that polarizes natural metabolites, enabling their use as agents for imaging tumor metabolism through magnetic resonance imaging (MRI). This technology transforms standard magnetic resonance spectrometers into tools capable of assessing human metabolism, thereby enhancing the precision of cancer diagnostics and facilitating real-time monitoring of patient responses to therapy. By leveraging advances in quantum physics, NVision aims to make significant strides in the medical imaging and diagnostics sector.

Fab'entech, founded in 2009 in Lyon, France, is a biopharmaceutical company that specializes in developing and commercializing innovative passive immunotherapeutic solutions. The company focuses on specific polyclonal immunoglobulins [F(ab’)₂] to address emerging infectious diseases and certain drug intoxications. By utilizing highly purified fragments of horse-specific polyclonal immunoglobulins, Fab'entech provides healthcare institutions with effective treatments for emergency situations. As a member of the LyonBiopôle cluster, the company is positioned within a network that fosters biotechnological advancements in the region.

Deutsche Glasfaser Holding GmbH, founded in 2012 and based in Borken, Germany, specializes in the planning, construction, and operation of fiber optic networks, particularly targeting rural and suburban areas. As a significant player in the broadband telecommunications sector, the company aims to facilitate nationwide fiber optic expansion, contributing to Germany's digital advancement. Deutsche Glasfaser focuses on delivering fast and cost-effective fiber-to-the-home (FTTH) connections in collaboration with municipalities, positioning itself as a leader in innovative planning and construction processes. With substantial backing from experienced investors, the company has established a strong financial foundation, making it one of the most robust providers in the German market.

Stark Future, founded in 2019 by Anton Wass and Paul Soucy, is a Spanish company with Swedish origins, located near Barcelona, Catalonia. The company focuses on developing electric motorcycles with the goal of reducing emissions and environmental impact through innovative technology and sustainable materials. Its first product, the Stark VARG, launched on December 14, 2021, features an 80-horsepower electric engine, a smartphone dashboard, and an app for bike setup. The VARG quickly gained popularity, achieving €9 million in advance sales within the first 24 hours and over 5,000 units sold in less than two months. Stark Future is committed to leading the transition to a sustainable motorcycle industry while providing high-performance options for environmentally conscious riders. The team's expertise includes former motocross world champion Sebastien Tortelli, who serves as the test manager, contributing to the company's commitment to excellence and innovation in electric motorcycle technology.

Protembis GmbH, founded in 2017 and based in Aachen, Germany, specializes in the manufacture of surgical equipment aimed at enhancing the safety of transcatheter aortic valve replacement (TAVR) procedures. The company has developed the ProtEmbo System, an intra-aortic filter device designed to mitigate the risk of cerebrovascular events during TAVR by deflecting embolic material away from the cerebral circulation. This innovation addresses a significant complication associated with TAVR, which has become a preferred treatment for patients with valvular heart disease, particularly as the procedure is increasingly performed on younger and lower-risk individuals. By minimizing the risk of brain injury, Protembis aims to improve patient outcomes and reduce healthcare costs related to surgical complications.

Nyxoah S.A. is a health-technology company based in Mont-Saint-Guibert, Belgium, established in 2009. The company specializes in developing and commercializing innovative solutions for treating sleep disordered breathing conditions, particularly moderate to severe obstructive sleep apnea (OSA). Its primary product, the Genio system, is a user-centered, bilateral neurostimulation therapy that has received CE-Mark validation. OSA is a prevalent condition linked to significant health risks, including increased mortality and various comorbidities such as cardiovascular diseases, depression, and stroke. Nyxoah aims to address these critical health challenges through its advanced therapeutic offerings.

XOCEAN Limited is a company that specializes in providing Data Collection-as-a-Service through its innovative uncrewed surface vessels (USVs). Founded in 2017 and based in Greenore, Ireland, XOCEAN focuses on delivering comprehensive ocean data solutions for surveyors, government bodies, and various offshore industries. The company's USVs are designed for unmanned operations over the horizon, utilizing satellite communications for real-time data acquisition, processing, and interpretation. XOCEAN also offers its CyberDeck, a secure cloud-based platform that enables remote monitoring and control of USVs, ensuring high-quality data collection while allowing adjustments to sensor parameters as needed. Their services encompass a range of applications, including seabed mapping, environmental monitoring, fisheries, bathymetry, and met ocean data. By leveraging proprietary technology, XOCEAN provides a safe, economical, and carbon-neutral approach to meeting the ocean data needs of its clients.

Intrinsic ID B.V. specializes in digital authentication solutions, primarily utilizing its proprietary SRAM Physical Unclonable Function (SRAM PUF) technology. Founded in 2008 and based in Eindhoven, the Netherlands, with operations in Korea, the company develops a range of products aimed at enhancing security for Internet of Things (IoT) and embedded applications. Its offerings include Broadkey, a secure key management software; Citadel, a key provisioning system; Quiddicard, which focuses on remotely programming keys; and Quiddikey, a solution for reconstructing on-chip secret keys without storage. These technologies are designed to validate payment systems, secure connectivity, authenticate sensors, and safeguard sensitive government and military data and systems.

Evonik Industries AG, headquartered in Germany, is a global specialty chemicals company. It operates in four major segments: specialty additives, smart materials, nutrition and care, and performance materials. Evonik produces and markets chemicals used in diverse industries, from automotive to pharmaceuticals, offering innovative solutions in areas such as animal nutrition, additives, smart materials, health care, and high-performance polymers. The company is a market leader in approximately 80% of its businesses and has a significant presence in Europe, North America, and Asia. Evonik Venture Capital, its corporate venture arm, invests in startups and venture capital funds with innovative technologies and high growth potential, focusing on areas such as resource efficiency, specialty additives, health & care, and nutrition.

Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies for patients with significant unmet medical needs, particularly in fibrosis, lysosomal storage disorders, and oncology. The company specializes in drugs that target nuclear receptors, transcription factors, and epigenetic modulation. Its primary product candidate, lanifibranor, is being developed for the treatment of non-alcoholic steatohepatitis (NASH), a condition currently lacking approved therapies. Inventiva has established a robust pipeline supported by a proprietary discovery engine, a dedicated research and development facility, and a skilled team with extensive experience in drug development. In addition to advancing lanifibranor, the company is also working on several earlier-stage programs aimed at addressing various medical conditions. All operations are conducted in France.

Volvo Car Group, established in 1927, is a global premium car manufacturer headquartered in Gothenburg, Sweden. It produces a range of vehicles including sedans, estates, cross country vehicles, SUVs, and convertibles, renowned for their intuitive Scandinavian design and focus on safety and sustainability. With sales in over 100 countries, Volvo Cars' largest markets are the United States, Sweden, China, Germany, and the UK. The company is committed to sustainable mobility, offering plug-in hybrid and electric cars, and is owned by Zhejiang Geely Holding of China. Volvo Car USA, based in Mahwah, New Jersey, is responsible for the production and sales of Volvo cars in the United States.

Zealand Pharma A/S is a biotechnology company based in Copenhagen, Denmark, specializing in the discovery and development of peptide-based medicines. The company has a growing proprietary pipeline that includes several clinical candidates such as glepaglutide for short bowel syndrome and dasiglucagon for diabetes management and congenital hyperinsulinism. Zealand's first developed medicine, lixisenatide, is a once-daily GLP-1 analogue for Type 2 diabetes, marketed globally outside the US. The company has established collaborations with major pharmaceutical partners, including Sanofi, Helsinn Healthcare, and Boehringer Ingelheim, enhancing its product offerings and expanding its reach in the market. Zealand Pharma is committed to advancing innovative therapies, with multiple projects in various stages of clinical development and preclinical research.

INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, that specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. Founded in 2019, the company offers the world's first brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation to provide adaptive and personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. Its technology enables continuous real-time monitoring and autonomous adjustments to therapy, enhancing therapeutic outcomes while reducing side effects. INBRAIN is also engaged in strategic collaborations, including with Merck KGaA, to expand its innovative solutions into peripheral nerve and systemic disease applications, thereby advancing the field of neurotechnology and bioelectronics.

VoltStorage GmbH, based in Olching, Germany, specializes in developing and producing power storage devices that utilize eco-friendly redox flow technology. The company's flagship product, VoltStorage, is a vanadium redox flow battery system designed to store excess electricity generated by solar panels during the day for use at night. This innovative approach enables homeowners to access renewable energy around the clock, promoting sustainability and environmental responsibility. In addition to its products, VoltStorage offers installation and technical support services, ensuring customers can effectively integrate these systems into their homes. The company aims to make renewable energy more accessible and contribute to a cleaner, fairer world for future generations.

Repsol is a Spanish integrated energy company that specializes in oil and gas production, as well as renewable energy solutions. With a daily production of 599,000 barrels of oil equivalent and proven reserves totaling 1.8 billion barrels, Repsol maintains a significant presence in the global energy market. The company operates a downstream segment with a refining capacity of 1 million barrels per day, complementing its upstream activities. Repsol is also focused on innovation and sustainable energy, having developed a renewable power generation capacity of 2.8 gigawatts. With operations in key energy regions such as Brazil, Russia, and the United States, Repsol is dedicated to creating a new energy model that encompasses both traditional and renewable energy sources.

Endesa is an electric utility company headquartered in Madrid, Spain, that generates, distributes, and supplies electricity primarily in Spain and Portugal. Founded in 1944, the company has an installed generation capacity of 22 gigawatts, utilizing a diverse mix of energy sources, including hydroelectric, nuclear, coal, natural gas, oil, solar, and wind. Endesa serves approximately 11.2 million customers and employs over 10,000 people. In addition to its core electricity services, Endesa operates in the natural gas sector and provides energy-related services, emphasizing a commitment to sustainability and technological innovation to address current and future energy challenges. The company also supplies gas to retail and business customers in Spain and France.

University College Cork is a prominent higher education institution located in Cork, Ireland, established in 1845. The university offers a diverse range of courses, encompassing fields such as Accounting, Zoology, and many others, catering to a broad spectrum of academic interests. Positioned dramatically on a limestone bluff, the campus provides an inspiring environment for students. University College Cork aims to address the evolving needs of higher education in Ireland, reflecting its commitment to fostering academic development and innovation. The institution's assets are overseen by a dedicated executive management team, ensuring effective governance and operational efficiency.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

Trucksters is a Madrid-based freight startup that provides long-haul transport services through a unique relay system. This innovative approach utilizes big data and artificial intelligence to enhance the efficiency of long-distance road transit. By implementing relays, Trucksters enables trucks to remain in continuous motion, significantly reducing delivery times and transportation costs. The company operates throughout the European Union and serves over 500 shippers, contributing to the electrification agenda and improving the working conditions for drivers. Through its advanced logistics solutions, Trucksters aims to optimize the global road freight industry.

Wingcopter GmbH, founded in 2014 and based in Darmstadt, Germany, specializes in the development and manufacture of advanced delivery drones for various applications, including medical supply chains and last-mile logistics. The company produces eVTOL, fixed-wing unmanned aircraft systems designed to efficiently deliver medicines, vaccines, blood, lab samples, parcels, and food to remote locations, as well as conduct inspections of public infrastructure. Its flagship model, the Wingcopter 198, features a patented tilt-rotor mechanism that allows for vertical takeoff and landing while maintaining the efficiency and range of a fixed-wing aircraft, even under challenging weather conditions. With a dedicated team of 120 professionals, Wingcopter aims to enhance and save lives through both commercial and humanitarian efforts, earning recognition as a Technology Pioneer by the World Economic Forum in 2020.

AT&S is a European manufacturer of printed circuit boards, specializing in high-end technology. The company provides a diverse array of printed circuit boards tailored to meet specific customer requirements, including double-sided plated-through, multi-layer, high-density interconnection, laser-drilled insulated metallic substrates, flexible, rigid-flex, and semi-flexible options. AT&S serves various core markets, such as mobile devices, automotive, industrial, medical, aviation, and advanced packaging. With a workforce of approximately 7,300 employees, including around 1,200 in Austria, AT&S is headquartered in Leoben, Austria. The company has demonstrated notable financial performance, achieving significant sales revenues in recent years.

Smart Reporting GmbH is a Munich-based company that specializes in providing a digital health solution for structured medical reporting, particularly in the fields of radiology and pathology. Established in 2014, the company offers an online platform that enables radiologists to generate high-quality medical reports through intelligent software that adheres to guideline-compliant criteria. The platform facilitates the creation of report templates, automatic text suggestions, and integration with hospital systems, thereby enhancing the efficiency and quality of medical reporting. Additionally, Smart Reporting provides tools for hospitals and practices to implement reporting standards, optimize templates, and ensure consistent report appearance across various physicians. The company also supports medical registries and clinical studies with solutions for structured reporting, data collection, and multilingual capabilities, all aimed at improving communication and quality assurance in medical documentation.

SiPearl is a French semiconductor company established in 2019, headquartered in Maisons-Laffitte, Île-de-France, with research and development centers located in France, Germany, and Spain. The company specializes in the design of high-performance, low-power microprocessors intended for exascale supercomputers, aligning its product development with the European Union’s technological goals. Its first microprocessor range, Rhea, is set for commercialization in early 2024 and is based on the Arm Neoverse V1 architecture. SiPearl is committed to manufacturing Rhea using advanced processes from TSMC, ensuring state-of-the-art performance. The microprocessors are aimed at a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, serving scientific researchers and major players in the IT, electronics, and automotive sectors.

GeNeuro is a biotechnology company based in Plan-Les-Ouates, Switzerland, specializing in the development of therapeutic drugs for diseases linked to pathogenic proteins originating from human endogenous retroviruses. The company primarily targets nervous system disorders, including multiple sclerosis and schizophrenia. Its lead product, GNbAC1, is a therapeutic monoclonal antibody designed to treat multiple sclerosis, while temelimab is another candidate that neutralizes a pathogenic protein from the HERV-W family. Additionally, GeNeuro is engaged in developing diagnostic tests to measure multiple sclerosis-associated retrovirus-ENV proteins in patients. Founded in 2006, the company is committed to addressing the underlying factors that drive the progression of neurodegenerative and autoimmune diseases.

Reden Solar specializes in the development, financing, construction, and operation of solar photovoltaic power plants across Europe and Latin America. With an installed portfolio of 762 megawatts and an additional 15 gigawatts under development, the company primarily focuses on markets in France and Spain, while also expanding its operations in Greece and Italy. Reden Solar provides a variety of photovoltaic solutions, including agricultural greenhouses, ground-mounted systems, shelters, and rooftop installations, aimed at promoting sustainable energy production and contributing to environmental conservation.

Orange is a global telecommunications company, founded in 1991 and headquartered in Paris, France. It operates in 30 countries across Europe and Africa, providing mobile and internet services to consumers, and corporate telecommunication services worldwide. Through its business arm, Orange Business Services, it caters to large corporates, local authorities, and SMEs, offering a comprehensive range of voice and data, IT, and integrated services. Additionally, Orange supports digital innovation through its international network of startup accelerators, Orange Fabs, which provides resources and expertise to startups in the digital space.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

AB Science is a France-based pharmaceutical company founded in 2001 by a team of researchers, clinicians, and entrepreneurs. It specializes in the research, discovery, development, and marketing of protein kinase inhibitors, focusing on targeted therapies using tyrosine kinase inhibitors. The company aims to address significant unmet medical needs in various fields, including cancer, chronic inflammatory diseases, neurological degenerative disorders, and central nervous system diseases. AB Science is committed to innovating and developing new drugs that can significantly improve the lives of patients and enhance treatment outcomes in both human and veterinary medicine.

Power Capital Renewable Energy Limited, founded in 2011 and based in Dublin, Ireland, focuses on the development, operation, and management of large-scale photovoltaic solar farms. The company specializes in all four stages of a solar asset's life cycle, including design, development, financing, construction, and operation. By acquiring and managing utility-scale solar parks, Power Capital aims to provide clean and reliable energy, contributing to the sustainability of the renewable energy sector. Their commitment to delivering competitive and sustainable energy solutions positions them as a significant player in the renewable energy market.

ExeVir Bio BV, founded in 2020 and based in Zwijnaarde, Belgium, specializes in developing single-domain antibody-based therapies aimed at combating viral infections. The company leverages a llama-derived antibody technology platform to create robust antiviral treatments that offer broad protection against coronaviruses. Notably, it is developing VHH72-FC, an antibody that targets a highly conserved region on the spikes of SARS-CoV-2, crucial for the virus's entry into human cells. ExeVir Bio's rapid response platform for antivirals allows for an agile approach to emerging health threats, enabling the swift generation of drug candidates. The therapeutics produced through this innovative technology are designed to be stable, cost-effective, and accessible on a global scale.

Cellectis S.A. is a clinical-stage biotechnological company based in Paris, France, focused on developing innovative immuno-oncology therapies using gene-edited T-cells. The company specializes in allogeneic Chimeric Antigen Receptor T-cell (CAR-T) products, with a portfolio that includes several product candidates targeting various hematologic malignancies. Notable candidates include UCART19, aimed at treating CD19-expressing hematologic cancers such as acute lymphoblastic leukemia; UCART123 for acute myeloid leukemia; and UCARTCS1 and ALLO-715 for multiple myeloma. In addition to its therapeutic efforts, Cellectis also produces high oleic soybean oil and other soybean products, as well as fiber wheat. The company collaborates with various strategic partners, including Allogene Therapeutics and The University of Texas M.D. Anderson Cancer Center. Founded in 1999, Cellectis continues to advance its mission of eradicating cancer through cutting-edge gene-editing technologies.

AB Science is a France-based pharmaceutical company founded in 2001 by a team of researchers, clinicians, and entrepreneurs. It specializes in the research, discovery, development, and marketing of protein kinase inhibitors, focusing on targeted therapies using tyrosine kinase inhibitors. The company aims to address significant unmet medical needs in various fields, including cancer, chronic inflammatory diseases, neurological degenerative disorders, and central nervous system diseases. AB Science is committed to innovating and developing new drugs that can significantly improve the lives of patients and enhance treatment outcomes in both human and veterinary medicine.

numares AG is a German company specializing in the development and marketing of software-based test systems for clinical diagnostics and life science research. Founded in 2004 and based in Regensburg, the company utilizes nuclear magnetic resonance (NMR) spectroscopy and machine learning to analyze metabolomic networks. Its AXINON in vitro diagnostic system produces numeric spectra that provide critical information regarding patients' disease statuses, particularly in the fields of cardiovascular diseases, nephrology, oncology, and neurology. By employing magnetic group signaling (MGS) technology, numares AG offers a reliable, efficient, and cost-effective solution for NMR-based diagnostics, positioning itself as a leader in commercial NMR analytics in Europe while providing expert support to its customers.

LeydenJar Technologies B.V. is a Netherlands-based company founded in 2016 that focuses on enhancing lithium-ion battery performance through the development of pure silicon anodes. By replacing traditional graphite anodes with innovative nanoporous silicon, LeydenJar Technologies significantly increases energy density, achieving a 70% improvement over current standards. This advancement not only leads to batteries with higher energy density of 1350Wh/L but also reduces costs by 20% and lowers the carbon footprint by 85%. The company's commitment to greener, more efficient battery technology positions it as a key player in the energy storage market.

Advicenne is a late-stage biopharmaceutical company founded in 2007 and headquartered in Nîmes, France. The company focuses on developing and commercializing innovative treatments for unmet medical needs in nephrology, particularly targeting orphan renal diseases and niche neurology indications. Its lead drug candidate, ADV7103, is undergoing late-stage clinical trials for two specific conditions: distal renal tubular acidosis (dRTA) and cystinuria. Advicenne aims to create pediatric-friendly therapeutics that enhance the lives of patients from early childhood through adulthood.

OVH APAC is a leading cloud provider known for its innovative and cost-effective solutions tailored for a diverse clientele, ranging from startups to large enterprises. Founded in 1999 by Octave Klaba and based in France, OVH offers a comprehensive portfolio of services, including web hosting, dedicated servers, cloud solutions, domain registration, and VOIP telephony. The company distinguishes itself through its proprietary global fiber-optic network and green data centers, which enable optimal performance and reliability. With a commitment to research and development and complete control over its supply chain, OVH delivers high-quality products and exceptional customer service. Additionally, OVH has established a strong partnership with VMware, integrating advanced software solutions to enhance network performance and streamline service delivery for its customers. As a result, OVH is recognized as one of the top internet hosting companies globally, serving millions of customers with cutting-edge technology and expertise.

GomSpace is a Danish space company founded in 2007 that specializes in the development and commercialization of nano-satellites. It offers turn-key solutions for various applications, including Internet of Things (IoT), communication, tracking, surveillance, and remote sensing. GomSpace provides a range of products such as professional nano-satellite solutions, commercial off-the-shelf sub-systems, software modules, and customizable payloads designed to meet specific customer requirements. The company operates across diverse sectors, including academia, commercial enterprises, defense, and scientific research, with a global presence that extends to Europe, the United States, Asia, and beyond. Through its innovative approach to nanosatellite technology, GomSpace aims to facilitate the growth of space-based businesses and services.

Energiefonds Overijssel is a venture capital firm established in 2012 and located in Zwolle, Netherlands. The company is dedicated to supporting the energy transition by providing financial contributions to initiatives and businesses that focus on energy savings or the generation of energy from renewable sources. Backed by the government, Energiefonds Overijssel prioritizes investments in renewable energy and clean energy technology, aiming to foster sustainable practices and innovation within the energy sector.

GenSight Biologics S.A. is a clinical-stage biotechnology company based in Paris, France, focused on developing gene therapy treatments for retinal degenerative diseases and neurodegenerative conditions affecting the central nervous system. Utilizing its core technology platforms—Mitochondrial Targeting Sequence and Optogenetics—the company aims to preserve and restore vision in patients with severe retinal disorders. Its lead product candidates include GS010, an AAV2-based gene therapy currently in Phase III trials for treating Leber hereditary optic neuropathy caused by mutations in the ND4 gene, and GS030, which is undergoing Phase I/II trials for retinitis pigmentosa and geographic atrophy in dry age-related macular degeneration. In addition to these, GenSight is advancing several products in preclinical stages targeting various ophthalmic and neurodegenerative diseases. Founded in 2012, the company is dedicated to innovative approaches that aim to prevent vision loss and improve the quality of life for affected patients.

Siltronic AG specializes in the development, production, and marketing of semiconductor wafers, serving various global markets. Founded in 1968 and headquartered in Munich, Germany, the company operates advanced manufacturing facilities across Asia, Europe, and the United States, with notable production sites for 200 mm and 300 mm wafers in Singapore. Siltronic's product offerings include polished wafers, epitaxial wafers, annealed wafers, floatzone products, and power products. The company has a diverse geographic presence, with segments in Germany, the rest of Europe, the United States, Taiwan, mainland China, South Korea, and other parts of Asia. With a workforce of approximately 3,600, Siltronic is positioned as a key player in the semiconductor industry.

SpinDiag GmbH is a medical technology company based in Freiburg, Germany, focused on developing automated point-of-care systems for the rapid and reliable detection of infectious diseases. Founded in 2016, the company has created a centrifugal-microfluidic test system that allows healthcare providers to screen for the 25 most common antibiotic resistances directly from patient samples upon hospital admission. This innovative system helps prevent the spread of drug-resistant bacteria by enabling the immediate isolation of infected patients. SpinDiag's first product is an automated SARS-CoV-2 test that provides laboratory-grade PCR results directly from standard patient swab samples, streamlining the workflow for nurses and integrating seamlessly into clinical practice. The fully automated system eliminates the need for manual pipetting, thereby minimizing the risk of infection and enhancing the efficiency of pathogen detection in hospital settings.

MithraSol specialises in the identification, development, construction and operation of Spanish solar photovoltaic assets and currently has 50MW of assets in development across twelve projects spanning central and southern Spain.

Aquila Capital is a private investment firm based in Hamburg, Germany, founded in 2001. It specializes in providing institutional investors, pension funds, foundations, and individuals with alternative investment solutions across real assets, financial markets, and private equity. The firm employs a multi-disciplinary investment approach, leveraging a team of dedicated specialists to manage a diverse range of investments, including hedge funds, private equity fund of funds, real estate, and infrastructure projects. Aquila Capital emphasizes strong operational frameworks and corporate governance to enhance its investment management capabilities. The firm operates additional offices in Frankfurt, Munich, and Vienna, and aims to identify and manage attractive investment opportunities for its clients through a solution-oriented approach that encompasses strategy development, implementation, and asset management.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

Opdenergy is an independent renewable energy producer with over 15 years of experience, specializing in solar photovoltaic and onshore wind energy. The company operates projects across several countries, including Spain, Chile, Italy, Mexico, and the USA, with the majority of its revenue generated from the Spanish market. Opdenergy's diverse portfolio reflects its commitment to advancing renewable technologies and contributing to sustainable energy solutions.

Blickfeld GmbH, established in 2017 and based in Munich, Germany, specializes in the production of LiDAR sensors and associated software. These sensors, based on patented silicon MEMS mirrors and commercial off-the-shelf components, measure direct distance information in 3D, enabling autonomous vehicles to perceive and analyze their surroundings. The company's object detection and mapping software processes data from these sensors, facilitating applications in city planning, connected mobility, real-time mapping, and usage pattern analysis. Blickfeld caters to the automotive, transportation, industrial, and robotics sectors, offering low-cost LiDAR systems to support the mass market's transition towards autonomous mobility and IoT applications.

Loci Orthopaedics Limited, based in Upper Newcastle, Ireland, specializes in developing innovative medical technologies to address significant unmet clinical needs in orthopedics. Founded in 2017, the company focuses on creating surgical implants, particularly the InDx implant, which is designed to treat arthritis in the thumb base joint. This implant uniquely mimics the natural motions of the thumb joint, offering a less invasive and easier insertion method compared to existing surgical options. Additionally, Loci Orthopaedics is known for its Osteoanchor surface architecture, which is based on evidence-based designs, enabling clinicians to effectively address challenges in orthopedic extremities.

Nomagic, Inc. is a company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce warehouses. By providing smart pick-and-place robotic systems, Nomagic enhances efficiency, flexibility, and reliability in the logistics process. Their technology automates repetitive tasks, reduces fulfillment costs, and addresses labor shortages, allowing warehouses to operate seamlessly around the clock. The company's robots have already been implemented on packing lines at Cdiscount, a leading French e-commerce platform. Utilizing artificial intelligence, Nomagic's systems continuously learn and adapt to changing conditions, improving the agility of warehouse operations and ensuring reliable delivery of goods.

Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies for patients with significant unmet medical needs, particularly in fibrosis, lysosomal storage disorders, and oncology. The company specializes in drugs that target nuclear receptors, transcription factors, and epigenetic modulation. Its primary product candidate, lanifibranor, is being developed for the treatment of non-alcoholic steatohepatitis (NASH), a condition currently lacking approved therapies. Inventiva has established a robust pipeline supported by a proprietary discovery engine, a dedicated research and development facility, and a skilled team with extensive experience in drug development. In addition to advancing lanifibranor, the company is also working on several earlier-stage programs aimed at addressing various medical conditions. All operations are conducted in France.

Cabify, established in 2011 and based in Madrid, Spain, is a ride-sharing company that facilitates transportation for both individuals and businesses. It offers a user-friendly web and mobile app for booking rides, connecting users with suitable transport options. Cabify prioritizes customer satisfaction, ensuring fair pricing, comfortable journeys, and accessibility for all. Its services include clean, modern vehicles driven by trained professionals, providing safe and reliable rides with added amenities like music and magazines. The company aims to enhance urban mobility and improve cities and communities by making transportation better.

Airborne International is engaged in engineering, manufacturing, and supplying high-end composites structures for industries such as aerospace, defense, marine, high-end bicycles, and formula-one cars. It offers composites structures maintenance and repair services, including inspection and damage assessment, sealing and painting, and balancing. The company was founded in 1995 and is based in The Hague, the Netherlands.

InstaFreight GmbH is a Berlin-based company that specializes in providing online freight forwarding services to B2B customers. Founded in 2016, InstaFreight aims to simplify the booking and processing of freight transport, making it fast and straightforward for businesses. The company focuses on delivering reliability, quality, and transparency, striving to become Europe's leading online freight forwarder. By offering innovative solutions and exceptional service, InstaFreight reduces the complexity of supply chains and enhances transparency for both customers and carriers.

Priothera Ltd is a clinical-stage company based in Dublin, Ireland, with an additional location in Saint Louis, France. It specializes in the development of orally applied sphingosine 1 phosphate (S1P) receptor modulators aimed at treating haematological malignancies. The company's primary focus is on its lead product, mocravimod, which is designed to enhance the curative potential of allogeneic haematopoietic stem cell transplants. By reducing the egress of T cell subsets from lymphatic tissues, Priothera's modulators aim to provide dual inhibition of graft versus host disease while also promoting graft versus leukemia effects, ultimately improving patient outcomes in this challenging area of medicine.

TRUMPF, a German high-technology company, is a global leader in manufacturing sheet metal fabrication machinery, industrial lasers, and medical technologies. It offers a wide range of production solutions, including laser cutting, welding, and marking systems, as well as punching and additive production equipment. TRUMPF Venture, established in 2016, is the company's corporate venture capital arm, investing in early-stage startups that operate in areas complementary or adjacent to TRUMPF's core business, such as advanced photonics and smart factories. The venture capital arm seeks innovative technologies and business models, and provides funded startups with access to its extensive network, deep domain expertise, and support for scaling and market entry. TRUMPF, as an independent, family-owned company, focuses on long-term strategies and continuous innovation to drive digital connectivity in manufacturing.

DyeMansion GmbH, established in Munich, Germany in 2013, specializes in post-processing and coloring of 3D-printed laser sintered parts. The company offers high-volume finishing systems that transform raw, 3D-printed parts into high-value consumer and industrial products, such as eyewear, automotive components, and medical devices. DyeMansion works with major 3D printing systems like EOS, HP, and 3D Systems, enabling precision coloring and finish to exact specifications. With over 400 customers, including leading global manufacturers, DyeMansion has become the global leader in additive manufacturing finishing systems for 3D-printed polymer parts.

DPG Media Group is a media company based in Antwerp, Belgium, specializing in the publication of newspapers, journals, and magazines. It provides a diverse array of news coverage, including entertainment, sports, politics, and market-related stories. In addition to its publishing activities, DPG Media offers advertising services to its clients, catering to a wide audience across Belgium. The company's content encompasses social, scientific, economic, and commercial topics, ensuring a comprehensive approach to media and information dissemination.

Starship Technologies, Inc. is a robotics company that specializes in the design and manufacture of self-driving delivery robots intended for local goods transportation. Founded in 2014, the company is headquartered in London, United Kingdom, with a research and development center in Estonia. Its autonomous robots are capable of delivering parcels, groceries, and food within a 30-minute timeframe, operating autonomously 99% of the time. These robots utilize a suite of sensors, including cameras and GPS, to ensure safe and efficient curb-side deliveries from local hubs. Starship Technologies aims to revolutionize the delivery process by providing convenient services that enhance everyday life while promoting environmentally friendly practices and reducing costs associated with local deliveries.

miDiagnostics is a Belgian company focused on creating innovative, chip-based technology for self-administered blood analysis. The company is developing a new generation of disposable tests that require only small drops of blood, allowing for the detection of various biomarkers, including cells, proteins, nucleic acids, and small molecules. Their technology integrates a nanofluidic processor on a chip with a compact reader, facilitating lab-quality diagnostics from easy-to-access samples like finger-prick blood or nasal swabs. This approach enables both patients and clinicians to conduct rapid diagnostics conveniently and efficiently, regardless of location.

Stilla Technologies is a biotechnology company based in Villejuif, France, with an additional location in Beverly, Massachusetts. Founded in 2013, the company specializes in accelerating the development of next-generation genetic tests through its innovative digital PCR (dPCR) solution, the Naica System. This platform leverages advanced microfluidic technology to provide a flexible and accessible tool for high-resolution genetic analysis. By enabling compatibility with multiple chemistries and offering multiplex capabilities, Stilla Technologies aims to simplify the processes of image analysis and data exploration for researchers in various fields, including life sciences and therapeutics. The company's mission is to make digital PCR a standard tool across all areas of genetic research and application.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels, utilizing a proprietary polymer-based technology called RestoreX. This technology enables the patient's natural healing system to develop tissue that permeates the heart valve, forming a new functional valve within it through a therapeutic approach called Endogenous Tissue Restoration (ETR). Xeltis' restorative devices include implantable small diameter blood vessels for hemodialysis vascular access and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. The company has secured significant funding from investors such as EQT Life Sciences, Kurma Partners, and the European Investment Bank, totaling over €30 million.

University College Dublin (UCD), founded in 1854, is a prominent research-intensive university located in Ireland. It is the largest and most diverse university in the country, with a student population exceeding 30,000 from around 124 nations. UCD provides a broad range of undergraduate and graduate programs, including fields such as accounting and biology. The institution emphasizes an innovative and flexible educational experience through its UCD Horizons curriculum, catering to the intellectual and personal development of students. UCD is particularly recognized for its graduate education, hosting approximately 7,000 graduate students and nearly 2,000 PhD candidates, with over half of its undergraduates continuing to pursue advanced studies. Through its commitment to research, innovation, and community engagement, UCD plays a vital role in fostering academic excellence and development in Ireland.

Ørsted is a Danish company specializing in the development and maintenance of offshore and onshore renewable energy farms, energy storage facilities, and bioenergy plants. Formerly known as DONG Energy, Ørsted has undergone a significant transformation over the past decade, committing to a vision of a world powered entirely by green energy. The company has dramatically reduced its coal consumption by 73% and aims to completely phase out coal by 2023. As a global leader in offshore wind, Ørsted holds a 25% market share, providing energy to approximately 9.5 million people. By the end of 2023, Ørsted operated 8.9 gigawatts of offshore wind capacity, with the United Kingdom being its largest market, followed by Germany and Denmark. The company is also expanding its presence outside Europe with projects in Taiwan and the United States, where it operates 4.8 gigawatts of onshore wind and solar assets. In addition to its renewable initiatives, Ørsted still engages in traditional utilities, including conventional power plants.

OSE Immunotherapeutics SA is a clinical-stage biotechnology company based in Nantes, France, specializing in the development of innovative immunotherapies aimed at immune activation and regulation, particularly in the areas of immuno-oncology and autoimmune diseases. The company's product portfolio includes Tedopi, which is in Phase III clinical trials for lung cancer and Phase II for pancreatic cancer; BI 765063, currently in Phase I trials for solid tumors; and OSE-703, a humanized monoclonal antibody in preclinical development for various cancers. Additionally, OSE Immunotherapeutics is advancing FR104, which is in Phase I trials for rheumatoid arthritis, and OSE-127, a humanized monoclonal antibody in Phase I trials for inflammatory autoimmune diseases. The company collaborates with notable partners such as GERCOR, Memorial Sloan Kettering Cancer Center, Boehringer Ingelheim, Servier, and HalioDx. OSE Immunotherapeutics was previously known as OSE Pharma SA before its name change in May 2016.

Bone Therapeutics SA is a biotechnology company based in Gosselies, Belgium, that specializes in the development of innovative cell therapy products for orthopedics and bone diseases. Established in 2006, the company has created a robust product pipeline, including ALLOB, an allogeneic cell therapy currently in Phase II clinical trials aimed at treating delayed-union fractures and spinal fusion procedures. Bone Therapeutics also conducts preclinical research on next-generation products, such as combined cell-matrix therapies for large bone defects and maxillofacial applications. The company collaborates with various partners to develop personalized, tissue-engineered bone implants, leveraging its extensive expertise in bone and joint physiology, along with advanced production methods and minimally invasive treatment techniques.

Red Points is a technology company focused on protecting brands from online counterfeiting, digital piracy, and distribution fraud. Established in 2011 and headquartered in Barcelona, Spain, Red Points offers a software-as-a-service (SaaS) platform that employs machine learning and computer vision to identify and eliminate counterfeit products and pirated content across more than one hundred online marketplaces and social networks. The platform processes hundreds of thousands of infringement incidents each month, assisting over five hundred brands globally, including well-known names such as Bang & Olufsen, MVMT, and DOPE. By providing effective solutions for brand protection, Red Points helps companies safeguard their intellectual property in the digital landscape.

Bouygues Telecom is a prominent telecommunications operator in France, offering a wide range of services that include mobile, fixed-line, television, internet, and cloud computing. The company serves approximately 11.1 million mobile customers and 2.1 million fixed broadband customers, including over 1.5 million professional and corporate clients. Renowned for its innovative approach, Bouygues Telecom has introduced several pioneering products, such as the first unlimited call plans, fixed-mobile convergence offers for corporate customers, and the quadruple play solution known as ideo. The company also launched B&YOU, a web-only offer that revolutionized mobile telephony. With a mobile network that covers 99% of the population and a rapidly expanding 4G network, Bouygues Telecom is committed to enhancing customer experience through its dedicated team of over 9,000 employees and a robust customer service framework that includes 2,000 advisers and 2,500 sales staff. The company's focus on innovation and customer satisfaction positions it as a key player in the French telecommunications market.

IDnow is a Munich-based company that specializes in identity verification technologies through its Identity-as-a-Service platform. Founded in 2014, IDnow employs advanced machine-learning techniques to offer real-time identity verification and electronic signing solutions, ensuring legal security and high data protection standards across Europe. Its services are tailored for business clients, including banks, telecommunications companies, and fintech firms, facilitating online customer identification and contract conclusion without the need for additional hardware. The platform allows users to verify their identities conveniently using smartphones, tablets, or webcams. IDnow's client roster features prominent organizations such as Commerzbank, UBS, Sixt neuwagen, Telefónica, and N26, highlighting its role as a key player in the identity verification sector.

Worldsensing is a leader in Internet of Things (IoT) solutions, specializing in low-power wireless sensing networks that enhance critical infrastructure. The company has developed comprehensive vertical solutions targeting two primary markets: Mobility and Industrial Solutions. In the Mobility sector, Worldsensing offers innovative products like Bitcarrier, a real-time traffic flow management system, and Fastprk, a leading smart parking solution. In the Industrial Solutions market, the LS-G6 platform is used to monitor vital assets in remote locations, including bridges, tunnels, and power lines. Founded in 2010, the company has established its presence in Barcelona and London, employing over 40 professionals. Worldsensing's achievements include multiple awards for its products, such as the Stockholm Smart City Living Labs Global Award for Fastprk and recognition from Gartner for Bitcarrier as a "Cool Vendor." The company is committed to providing clients with real-time insights to improve decision-making in both smart city and industrial contexts.

Spire Global, Inc., established in 2012 and headquartered in San Francisco with offices in Glasgow and Singapore, specializes in satellite data services. The company offers two primary data services: Spire Sense, which provides ship tracking data for applications such as illegal fishing monitoring, trade analysis, and maritime domain awareness; and Spire Stratus, which delivers global weather data. Additionally, Spire Global provides machine learning and analytics tools to enhance vessel detection and information gathering. Its clients include mining companies, government authorities, port operators, and those involved in arctic shipping routes.

Robart is an Austrian high-tech start-up established in 2009, dedicated to creating autonomous mobile robots for both consumer and industrial use, leveraging its proprietary Artificial Intelligence Control Unit (AICU) technology. The company aims to revolutionize everyday life by developing affordable robotic solutions, including intelligent vacuum cleaners and security robots, that can effectively navigate and adapt to dynamic home environments. By focusing on robust functionality and intuitive user interaction, Robart addresses the shortcomings of current robotic offerings, ensuring that its products not only meet but exceed consumer expectations. The company's innovative approach positions it as a key player in the next generation of intelligent robotics, with a vision of making a robot accessible for every household.

Magazino GmbH, founded in 2014 and based in Munich, Germany, specializes in developing and manufacturing mobile robots for the storage and intralogistics sectors. The company offers advanced mobile pick-and-place robots designed for e-commerce warehouses, capable of identifying and localizing individual items using 2D and 3D cameras. These robots operate collaboratively as part of a swarm, utilizing the ACROS (Advanced Cooperative Robot Operating System) to receive and execute orders. Additionally, Magazino provides the App ARC (ACROS Robot Control) for monitoring robot fleets. Their technology aims to simplify and automate daily operations for mail-order companies, warehouses, production lines, and pharmacies, ultimately contributing to the evolution of robotics and the future of logistics.

ESB International is an expanding energy company and a prominent engineering and consultancy organization in Europe. It is responsible for managing the non-regulated operations of its parent company, ESB, and engages in a wide range of activities within the energy sector. ESB International specializes in providing engineering design, construction management, and strategic consultancy services to clients both in Ireland and globally, particularly within the power sector. The firm focuses on supporting energy utilities and business developers, leveraging its expertise to address the diverse challenges in the energy industry.

Advicenne is a late-stage biopharmaceutical company founded in 2007 and headquartered in Nîmes, France. The company focuses on developing and commercializing innovative treatments for unmet medical needs in nephrology, particularly targeting orphan renal diseases and niche neurology indications. Its lead drug candidate, ADV7103, is undergoing late-stage clinical trials for two specific conditions: distal renal tubular acidosis (dRTA) and cystinuria. Advicenne aims to create pediatric-friendly therapeutics that enhance the lives of patients from early childhood through adulthood.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

NavVis GmbH, established in 2013 and headquartered in Munich, Germany, specializes in indoor spatial intelligence solutions. The company offers the NavVis M6, a mobile mapping system that captures 360° immersive imagery and point clouds, and NavVis IndoorViewer, a platform that combines these data to create digital twins of physical spaces. These solutions serve various industries, including automotive, construction, real estate, and insurance, aiding in CAD/BIM modeling, factory planning, and indoor mapping. NavVis' technology enables enterprises to bridge the gap between the physical and digital worlds, facilitating better operational decisions and improved productivity.

CureVac is a clinical-stage biopharmaceutical company based in Germany, established in 2000, that specializes in developing vaccines and therapies utilizing messenger ribonucleic acid (mRNA). The company focuses on both prophylactic and therapeutic applications of mRNA, enabling the human body to produce proteins that combat various diseases. CureVac's innovative pipeline includes mRNA-based cancer immunotherapies, such as CV9104, which is in Phase IIb development for prostate cancer, as well as RNActive vaccines against infectious diseases and RNArt molecular therapies designed to stimulate the production of therapeutic proteins. Additionally, the company has collaborated with GSK to advance second-generation vaccines for seasonal influenza and COVID-19, alongside an avian influenza vaccine, while also exploring mRNA therapies for oncology and other conditions affecting the liver and eyes.

BioNTech is a Germany-based biotechnology company that specializes in developing innovative immunotherapies for cancer and other serious diseases, as well as vaccines for infectious diseases, including COVID-19. The company’s oncology pipeline includes a range of drug classes, such as mRNA-based drugs that encode antigens and neoantigens, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech has established partnerships with several major pharmaceutical companies, enhancing its research and development capabilities. Its COVID-19 vaccine, Comirnaty, represents its first commercialized product, demonstrating the company's commitment to addressing urgent health challenges through advanced therapeutic approaches.

AM Pharma B.V. is a biopharmaceutical company based in Bunnik, the Netherlands, focused on developing and commercializing novel therapeutics for inflammatory and infectious diseases. Established in 2000, the company specializes in pre-clinical and clinical development using endogenous proteins and peptides derived from the human body. Its key products include alkaline phosphatase, aimed at treating acute kidney injury and ulcerative colitis, and the immune response amplifying peptide hLF1-11, which targets drug-resistant hospital-acquired infections. AM Pharma is committed to providing innovative therapies that enhance patient quality of life by addressing critical medical needs.

ITM Isotopen Technologien München AG is a biotechnology and radiopharmaceutical company based in Garching, Germany, focusing on the development, manufacturing, and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radionuclides for cancer treatment. Established in 2004, ITM has built a robust global supply network and accomplished GMP manufacturing capabilities. The company offers a range of products, including EndolucinBeta, a radiopharmaceutical precursor for targeted radionuclide therapy, as well as radionuclides like 225Ac and 213Bi. Additionally, ITM develops automated systems for synthesizing radiolabeled biomolecules and provides GMP radiolabeling services. With a growing portfolio of innovative treatments and partnerships, ITM aims to enhance patient outcomes and quality of life in oncology, specifically addressing conditions such as neuroendocrine cancers and bone metastases while minimizing side effects.

Azimo, established in 2012, is a London-based digital money transfer company that operates globally. It offers a user-friendly mobile app for sending money internationally, either to bank accounts or over 270,000 cash pick-up points worldwide. Azimo's platform is designed to be fast, secure, and cost-effective, providing an alternative to traditional high street remittance services. It supports both Android and iOS devices, enabling users to transfer funds from any internet-connected device.

Telefónica Deutschland is a prominent integrated telecommunications provider based in Munich, Germany, offering a wide range of mobile and fixed services for both private and business customers. The company manages approximately 49.6 million customer lines, with over 45 million in the mobile segment alone. Telefónica Deutschland's offerings include postpaid and prepaid mobile products, mobile data services utilizing GPRS, UMTS, and LTE technologies, as well as DSL fixed network telephony and high-speed internet services. Following its integration of E-Plus, the company is committed to digitalizing its business model while enhancing customer experience. With aspirations to become the preferred partner in the German mobile service market, Telefónica Deutschland aims to simplify and improve its customers' lives, providing them with mobile freedom in an increasingly digital world.

On Robot manufactures robot equipment for automation tasks throughout the industry. It provides plug and produce end-of-arm tools and software solutions that help manufacturers take full advantage of the benefits of collaborative robots. The company integrates grippers, sensors, and other cobot equipment to facilitate the use of technology in applications such as packaging, quality testing, material handling, machine tending, assembly, and welding. On Robot was founded in 2015 and is based in Odense, Denmark.

Median Technologies SA specializes in the development and marketing of software products and platforms for medical image analysis, primarily focusing on oncology. Founded in 2002 and headquartered in Valbonne, France, the company operates internationally, offering solutions that enhance the diagnosis and treatment of cancer patients. Its key products include iBiopsy, an imaging platform that utilizes AI for biomarker identification, and iSee, which supports image analysis and management in clinical trials. Additionally, Median provides a range of imaging contract research services, including study startup, data management, and scientific consulting to optimize clinical trials. The company collaborates with a contract research organization and Canon to enhance its imaging technologies and services, aiming to improve patient care and streamline drug development processes.

BioNTech is a Germany-based biotechnology company that specializes in developing innovative immunotherapies for cancer and other serious diseases, as well as vaccines for infectious diseases, including COVID-19. The company’s oncology pipeline includes a range of drug classes, such as mRNA-based drugs that encode antigens and neoantigens, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech has established partnerships with several major pharmaceutical companies, enhancing its research and development capabilities. Its COVID-19 vaccine, Comirnaty, represents its first commercialized product, demonstrating the company's commitment to addressing urgent health challenges through advanced therapeutic approaches.